Name: Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: CH3482
Price: 4950 USD
Availability: InStock

報告摘要

The pharmaceutical packaging market is projected to reach USD 364.11 billion by 2030 from USD 174.85 billion in 2025, at a CAGR of 15.8% during the forecast period. The pharmaceutical packaging market is witnessing significant growth opportunities, partly fueled by increasing demand for safe, reliable, and patient-centric packaging solutions across a variety of sectors, including hospitals, retail pharmacies, and e-pharmacies. Pharmaceutical packaging maintains the integrity of the product, stops it from becoming contaminated, and allows for convenient and safe delivery of the drug. In addition, as regulatory- and safety-motivated concerns mount, the US. The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) will push for greater requirements around materials, serialization, and anti-counterfeiting. Manufacturers of vehicles will begin increasing the conceptual development of good packaging systems, like those that are tamper-evident, child-resistant, and smart packaging. Safety, regulatory compliance, and packaging systems for children will push the industry to introduce digital and track-and-trace technologies, such as packaging enabled with RFID or QR codes. Pharmaceutical packaging will be moveable and influential in the ongoing evolution of investment in drug safety, product authenticity, and patient-specific features for a system of healthcare delivery in the future. “By packaging type, primary packaging is projected to be the fastest-growing packaging type during the forecast period.” In the forecast period, primary packaging is projected to be the fastest-growing type of pharmaceutical packaging. This segment will grow because primary packaging is directly responsible for drug stability, sterility, and patient safety, particularly for more sensitive drugs, such as biologics and injectables. For example, the increasing demand for prefilled syringes, blister packs, vials, and ampoules indicates the manufacturing growth of pharmaceuticals and the desire for patients to have drugs packaged in more convenient formats ready for use. In addition, primary packaging is important in meeting regulatory challenges and serialization requirements. It also addresses concerns regarding tamper evidence and counterfeiting. Advances in barrier coatings, smart labels, and child-resistant closures will enhance functionality and product demand in global health care markets. “By drug delivery, oral drugs are estimated to account for the second-largest market during the forecast period.” Oral drug delivery is estimated to account for the largest portion of the pharmaceutical packaging market in 2024 among the delivery methods for drug delivery systems. The packaging formats related to oral drug delivery are tablets, capsules, and oral liquids, primarily because of their convenience, affordability, and ability to promote adherence, or compliance, among patients. The packaging formats for oral solid doses will include blister packs and bottles, due to their portability, ability for unit dose, and ability to protect the dose from moisture and other contaminants. Increasing trend towards self-medication, in particular in the over-the-counter self-medication market, is also driving the demand for user-friendly oral drug delivery packaging. In addition, manufacturers continue to enhance oral drug packaging with sustainable aspects and easier access for older adults (e.g., easy-to-open and clearly labeled dosage designs). “By raw material, paper & paperboard is set to account for the second-largest market share during the forecast period.” For the duration of the forecast period, paper & paperboard packaging is estimated to account for the second biggest market share in the pharmaceutical packaging market because this packaging type is mostly relevant to the secondary and tertiary packaging applications. The recyclable qualities of paper and paperboard materials, price advantage, and support for sustainability goals come to the forefront as pharmacy manufacturers respond to both societal and legislative pressures to limit plastic usage. The use of paperboard cartons, leaflets, and labels plays a key role in product identification, such as dose direction and legislative requirements for serialization and anti-counterfeiting, and tracking sustainability disposal practices. The sustainable focus on limited usage of plastics and overall desire to conform to the principles of a circular economy will continue to be drivers of the paper-based pharmaceutical packaging markets in developed regions, especially where sustainability initiatives are a priority. “Asia Pacific is projected to account for the second-largest market share in the pharmaceutical packaging market during the forecast period.” In 2024, the Asia Pacific region accounted for the second largest share within the global pharmaceutical packaging market. The sustained strength of the region is principally based upon its growing pharmaceutical manufacturing base, particularly in emerging markets such as China, India, and Japan, which are prime markets for the development of generic and branded drug products. Growth in healthcare expenditures, a growing middle-class population, and improved access to healthcare services are increasing demand for pharmaceuticals, which is also driving demand for advanced pharmaceutical packaging offerings. This trend is also supported by an increase in chronic diseases and governmental policies aimed at establishing an effective domestic supply chain for medications, both for driving the need for safe and effective pharmaceutical packaging. The growth of contract manufacturing and pharmaceutical packaging services continues to expand in the Asia Pacific region, with attendant levels of investment from established companies, allowing these players to benefit from lower-cost production capabilities and scaled efficiencies. The combination of the previously outlined trends will substantiate the Asia Pacific region as a major contributor to the accelerated growth associated with the global pharmaceutical packaging market. By Company Type: Tier 1: 25%, Tier 2: 42%, and Tier 3: 33% By Designation: C-level Executives: 20%, Directors: 30%, and Other Designations: 50% By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa: 20% Notes: Other designations include sales, marketing, and product managers. Tier 1: Greater than USD 1 Billion; Tier 2: Between USD 500 million and USD 1 Billion; and Tier 3: Less than USD 500 million Companies Covered: Amcor PLC (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Aptar Group, Inc. (US), BD (US), WestRock Company (US), NIPRO Corporation (Japan), Catalent Inc. (US), Sealed Air (US), and West Pharmaceutical Services (US) are covered in the report. The study includes an in-depth competitive analysis of these key players in the pharmaceutical packaging market, with their company profiles, recent developments, and key market strategies. Research Coverage This research report categorizes the pharmaceutical packaging market based on type (plastic bottles, blister packs, caps & closures, prefilled syringes, pouches & strips, prefilled inhalers, vials, ampoules, cartridges, labels & accessories, medical specialty bags, temperature-controlled packaging, medication tubes, and jars & canisters), drug delivery (oral drugs, pulmonary, transdermal, injectables, topical, nasal, ocular/ophthalmic and iv drugs), packaging type (primary and secondary) by raw material (plastics, paper & paperboard, and glass, metal) and region (Asia Pacific, North America, Europe, South America, and Middle East & Africa). The report’s scope covers detailed information regarding the drivers, restraints, challenges, and opportunities influencing the growth of the pharmaceutical packaging market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as partnerships, collaborations, mergers, acquisitions, product launches, and expansions, associated with the pharmaceutical packaging market. This report covers a competitive analysis of upcoming startups in the pharmaceutical packaging market ecosystem. Reasons to Buy the Report The report will offer the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall pharmaceutical packaging market and the subsegments. This report will help stakeholders understand the competitive landscape, gain more insights into positioning their businesses better, and plan suitable go-to-market strategies. The report will help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following points: •Assessing the major drivers (growing healthcare expenditure and pharmaceutical industry in emerging economies, increasing demand for drug delivery devices and blister packaging, and technological advancements contributing to the growth of pharmaceutical packaging), restraints (increasing overall packaging costs owing to dynamic regulatory policies and lack of access to proper healthcare), opportunities (growing demand for primary pharmaceutical packaging and expansion of personalized medicine), and challenges (safeguarding against counterfeit products and balancing innovations with cost efficiency). •Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the pharmaceutical packaging market. •Market Development: Comprehensive information about profitable markets – the report analyzes the pharmaceutical packaging market across varied regions. •Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmaceutical packaging market. •Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Aptar Group, Inc. (US), BD (US), WestRock Company (US), NIPRO (Japan), Catalent Inc. (US), Sealed Air (US), and West Pharmaceutical Services (US), among others.

目錄 Table of Contents

1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 STUDY SCOPE 29 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 29 1.3.2 INCLUSIONS AND EXCLUSIONS 30 1.3.3 YEARS CONSIDERED 31 1.3.4 UNITS CONSIDERED 31 1.3.4.1 Currency/Value unit 31 1.3.4.2 Volume unit 31 1.4 LIMITATIONS 31 1.5 STAKEHOLDERS 32 1.6 SUMMARY OF CHANGES 32 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 2.1.1 SECONDARY DATA 34 2.1.1.1 List of key secondary sources 34 2.1.1.2 Key data from secondary sources 34 2.1.2 PRIMARY DATA 35 2.1.2.1 Key data from primary sources 35 2.1.2.2 Key industry insights 36 2.1.2.3 Breakdown of primary interviews 36 2.2 MARKET SIZE ESTIMATION 37 2.2.1 BOTTOM-UP APPROACH 37 2.2.2 TOP-DOWN APPROACH 38 2.3 DATA TRIANGULATION 38 2.4 RESEARCH ASSUMPTIONS 40 2.5 GROWTH RATE FORECAST/ASSESSMENT 40 2.5.1 SUPPLY SIDE 41 2.5.2 DEMAND SIDE 41 2.6 RISK ASSESSMENT 41 2.7 LIMITATIONS 41 3 EXECUTIVE SUMMARY 42 4 PREMIUM INSIGHTS 47 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET 47 4.2 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 47 4.3 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 48 4.4 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 48 4.5 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY 49 4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY 49 5 MARKET OVERVIEW 50 5.1 INTRODUCTION 50 5.2 MARKET DYNAMICS 50 5.2.1 DRIVERS 51 5.2.1.1 Growing healthcare expenditure and pharmaceutical industry in emerging economies 51 5.2.1.2 Rising demand for drug delivery devices and blister packaging 52 5.2.1.3 Technological advancements in pharmaceutical packaging 52 5.2.2 RESTRAINTS 53 5.2.2.1 Increase in overall packaging costs due to dynamic regulatory policies 53 5.2.2.2 Lack of access to proper healthcare in emerging economies 53 5.2.3 OPPORTUNITIES 54 5.2.3.1 Growing demand for primary pharmaceutical packaging 54 5.2.3.2 Growth in personalized medicine 54 5.2.4 CHALLENGES 55 5.2.4.1 Safeguarding counterfeit products 55 5.2.4.2 Balancing innovations with cost efficiency 55 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55 5.4 ECOSYSTEM ANALYSIS 56 5.5 VALUE CHAIN ANALYSIS 58 5.6 REGULATORY LANDSCAPE 59 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59 5.6.2 REGULATIONS 62 5.6.2.1 21 CFR Part 211 - Current Good Manufacturing Practice (cGMP) for Finished Pharmaceuticals (USA) 62 5.6.2.2 Federal Anti-Tampering Act (USA, 1983) 62 5.6.2.3 Fair Packaging and Labeling Act (FPLA, USA, 1967) 62 5.6.2.4 Good Manufacturing Practices (GMP - WHO Guidelines) 62 5.6.2.5 ISO 15378:2017 - Primary Packaging Materials for Medicinal Products 62 5.6.2.6 European Pharmacopoeia (Ph. Eur.) 63 5.6.2.7 United States Pharmacopeia (USP) 63 5.6.2.8 Japanese Pharmacopoeia (JP) 63 5.6.2.9 Regulation (EU) 2017/745 on Medical Devices (MDR – Europe) 63 5.6.2.10 International Council for Harmonisation (ICH) Guidelines 63 5.7 TRADE ANALYSIS 63 5.7.1 IMPORT SCENARIO (HS CODE 392310) 63 5.7.2 EXPORT SCENARIO (HS CODE 392310) 64 5.8 PRICING ANALYSIS 65 5.8.1 INDICATIVE AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY RAW MATERIAL 66 5.8.2 AVERAGE SELLING PRICE TREND, BY REGION 66 5.9 TECHNOLOGY ANALYSIS 67 5.9.1 KEY TECHNOLOGIES 67 5.9.1.1 Nanotechnology 67 5.9.1.2 Packaging food biologics 67 5.9.2 COMPLEMENTARY TECHNOLOGIES 68 5.9.2.1 Smart packaging 68 5.9.3 ADJACENT TECHNOLOGIES 68 5.9.3.1 Anti-counterfeit technology 68 5.10 PATENT ANALYSIS 68 5.10.1 INTRODUCTION 68 5.10.2 LEGAL STATUS OF PATENTS 70 5.10.3 JURISDICTION ANALYSIS 70 5.11 CASE STUDY ANALYSIS 71 5.11.1 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY 71 5.11.2 CUSTOM TECHNOLOGY FOR BETTER BREATHING 71 5.11.3 STREAMLINING OPERATIONS AND REDUCING COSTS THROUGH MD LOGISTICS 72 5.12 KEY CONFERENCES AND EVENTS 73 5.13 INVESTMENT AND FUNDING SCENARIO 74 5.14 IMPACT OF GEN AI/AI ON PHARMACEUTICAL PACKAGING MARKET 74 5.14.1 INTRODUCTION 74 5.14.2 AI-POWERED TRACKING AND BLOCKCHAIN INTEGRATION 74 5.14.3 ENHANCING PHARMACEUTICAL SECURITY THROUGH AI 75 5.14.4 SMART AND CONNECTED DRUG PACKAGING 75 5.15 PORTER’S FIVE FORCES ANALYSIS 75 5.15.1 THREAT OF NEW ENTRANTS 76 5.15.2 THREAT OF SUBSTITUTES 76 5.15.3 BARGAINING POWER OF BUYERS 76 5.15.4 BARGAINING POWER OF SUPPLIERS 77 5.15.5 INTENSITY OF COMPETITIVE RIVALRY 77 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 77 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 77 5.16.2 BUYING CRITERIA 79 5.17 MACROECONOMIC ANALYSIS 80 5.17.1 INTRODUCTION 80 5.17.2 GDP TRENDS AND FORECASTS 80 5.18 IMPACT OF 2025 US TARIFFS ON PHARMACEUTICAL PACKAGING MARKET 81 5.18.1 INTRODUCTION 81 5.18.2 KEY TARIFF RATES 81 5.18.3 IMPACT ON COUNTRY/REGION 81 5.18.3.1 US 81 5.18.3.2 Europe 81 5.18.3.3 Asia Pacific 81 5.18.4 IMPACT ON TYPES 82 5.18.4.1 Plastic bottles 82 5.18.4.2 Medication tubes 82 5.18.4.3 Other types 82 6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 83 6.1 INTRODUCTION 84 6.2 PRIMARY 85 6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET 85 6.3 SECONDARY 85 6.3.1 RISE IN ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND 85 7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 86 7.1 INTRODUCTION 87 7.2 PLASTIC 89 7.2.1 EXCELLENT BARRIER PROPERTIES AND COST-EFFECTIVENESS TO DRIVE MARKET 89 7.2.2 HIGH-DENSITY POLYETHYLENE 90 7.2.3 POLYESTER 90 7.2.4 POLYPROPYLENE 90 7.2.5 LOW-DENSITY POLYETHYLENE 90 7.2.6 POLYVINYL CHLORIDE 91 7.2.7 CYCLIC OLEFIN COPOLYMER 91 7.2.8 POLYETHYLENE TEREPHTHALATE 91 7.3 PAPER & PAPERBOARD 91 7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET 91 7.4 GLASS 93 7.4.1 CHEMICAL RESISTANCE AND EFFECTIVE PROTECTION TO BOOST MARKET 93 7.5 METAL 95 7.5.1 INCREASE IN USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET 95 7.6 OTHER RAW MATERIALS 96 8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY 98 8.1 INTRODUCTION 99 8.2 ORAL 101 8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET 101 8.3 INJECTABLE 102 8.3.1 RISE IN USE OF BIOLOGICS TO BOOST MARKET 102 8.4 TOPICAL 103 8.4.1 RISE IN PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS 103 8.5 OCULAR/OPHTHALMIC 104 8.5.1 INCREASE IN PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET 104 8.6 NASAL 105 8.6.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS 105 8.7 PULMONARY 106 8.7.1 RISE IN CASES OF LUNG DISORDERS TO DRIVE MARKET 106 8.8 TRANSDERMAL 107 8.8.1 RISE IN DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET 107 8.9 INTRAVENOUS 108 8.9.1 HIGH OCCURRENCE OF CHRONIC DISEASES TO DRIVE DEMAND 108 8.10 OTHER DRUG DELIVERY MODES 109 9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 111 9.1 INTRODUCTION 112 9.2 PLASTIC BOTTLES 114 9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO DRIVE DEMAND 114 9.2.2 STANDARD PLASTIC BOTTLES 115 9.2.3 PLASTIC DISPENSING BOTTLES 115 9.2.4 PLASTIC JARS 116 9.3 BLISTER PACKS 116 9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET 116 9.3.2 COMPARTMENT PACKS 117 9.3.3 WALLET PACKS 117 9.4 LABELS & ACCESSORIES 117 9.4.1 STRINGENT GUIDELINES REGARDING DRUG INSTRUCTIONS TO DRIVE MARKET 117 9.4.2 SELF-ADHESIVE 118 9.4.3 DIE-CUT 118 9.4.4 HOLOGRAPHIC STRIPS 119 9.4.5 TAMPER-PROOF 119 9.4.6 OTHER LABELS & ACCESSORIES 119 9.5 CAPS & CLOSURES 119 9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET 119 9.6 MEDICAL SPECIALTY BAGS 120 9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND 120 9.7 PREFILLED SYRINGES 121 9.7.1 RISE IN NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET 121 9.8 TEMPERATURE-CONTROLLED PACKAGING 122 9.8.1 RISE IN DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET 122 9.9 POUCHES & STRIP PACKS 123 9.9.1 RISE IN DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET 123 9.10 AMPOULES 124 9.10.1 GROWTH IN DEMAND FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET 124 9.11 VIALS 125 9.11.1 DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE GROWTH 125 9.12 PREFILLED INHALERS 126 9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET 126 9.12.2 METERED DOSE INHALERS 127 9.12.3 DRY POWDER INHALERS 127 9.13 MEDICATION TUBES 128 9.13.1 INCREASE IN DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET 128 9.13.2 COMPOSITE TUBES 129 9.13.3 ALL-PLASTIC TUBES 129 9.13.4 COLLAPSIBLE METAL TUBES 129 9.14 JARS & CANISTERS 129 9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS 129 9.15 CARTRIDGES 130 9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET 130 9.16 OTHER TYPES 131 10 PHARMACEUTICAL PACKAGING MARKET, BY REGION 133 10.1 INTRODUCTION 134 10.2 NORTH AMERICA 135 10.2.1 US 140 10.2.1.1 Rapid technological advancements in pharmaceutical packaging to fuel growth 140 10.2.2 CANADA 142 10.2.2.1 Expansion of pharmaceutical industry and increase in consumption of pharmaceutical products to boost market 142 10.2.3 MEXICO 144 10.2.3.1 Increase in chronic diseases and presence of free-trade agreements to fuel demand for pharmaceutical products 144 10.3 EUROPE 146 10.3.1 GERMANY 152 10.3.1.1 Investment in innovations in biologics and sustainable materials, aligning with EU regulations on packaging waste reduction to drive market 152 10.3.2 FRANCE 154 10.3.2.1 High demand for generic drugs and investment in biotherapies to drive market 154 10.3.3 ITALY 156 10.3.3.1 Rise in exports of pharmaceuticals to boost market 156 10.3.4 UK 158 10.3.4.1 Innovations in drug manufacturing with reliable legal system and strong protection of intellectual property to drive market 158 10.3.5 SPAIN 160 10.3.5.1 High-quality, cost-effective manufacturing capabilities, well-established R&D facilities in healthcare sector to boost demand 160 10.3.6 RUSSIA 162 10.3.6.1 Government initiatives for domestic production of pharmaceuticals to fuel market 162 10.3.7 REST OF EUROPE 164 10.4 ASIA PACIFIC 166 10.4.1 CHINA 172 10.4.1.1 Increased investments in R&D of biologics and biosimilar drugs to drive market 172 10.4.2 JAPAN 174 10.4.2.1 Global leader in product innovation with sizeable aging population to drive demand for medications 174 10.4.3 SOUTH KOREA 176 10.4.3.1 Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market 176 10.4.4 INDIA 178 10.4.4.1 Large domestic consumption and export of generic drugs to drive market 178 10.4.5 AUSTRALIA 180 10.4.5.1 Wide adoption of Medicare and PBS schemes to drive market 180 10.4.6 REST OF ASIA PACIFIC 182 10.5 SOUTH AMERICA 184 10.5.1 BRAZIL 189 10.5.1.1 Large availability of required raw materials, cost-effective labor, and robust regulatory policies to boost market 189 10.5.2 ARGENTINA 191 10.5.2.1 Prevalence of noncommunicable diseases to boost market despite sharp economic deceleration, remediated by government stabilization measures 191 10.5.3 REST OF SOUTH AMERICA 193 10.6 MIDDLE EAST & AFRICA 195 10.6.1 SAUDI ARABIA 201 10.6.1.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals 201 10.6.2 UAE 203 10.6.2.1 Increasing initiatives for domestic pharmaceutical production to drive market 203 10.6.3 SOUTH AFRICA 205 10.6.3.1 Gradual rise in generic drug use to drive market 205 10.6.4 REST OF MIDDLE EAST & AFRICA 206 11 COMPETITIVE LANDSCAPE 209 11.1 OVERVIEW 209 11.2 KEY PLAYER STRATEGIES 209 11.3 MARKET SHARE ANALYSIS 211 11.4 REVENUE ANALYSIS 214 11.5 COMPANY VALUATION AND FINANCIAL METRICS 215 11.5.1 COMPANY VALUATION 216 11.5.2 FINANCIAL METRICS 216 11.6 PRODUCT/BRAND COMPARISON 217 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 219 11.7.1 STARS 219 11.7.2 EMERGING LEADERS 219 11.7.3 PERVASIVE PLAYERS 219 11.7.4 PARTICIPANTS 219 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 221 11.7.5.1 Company footprint 221 11.7.5.2 Regional Footprint 221 11.7.5.3 Raw material footprint 222 11.7.5.4 Type footprint 223 11.7.5.5 Drug delivery footprint 224 11.7.5.6 Packaging type footprint 225 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 225 11.8.1 PROGRESSIVE COMPANIES 225 11.8.2 RESPONSIVE COMPANIES 225 11.8.3 DYNAMIC COMPANIES 226 11.8.4 STARTING BLOCKS 226 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 227 11.8.5.1 Detailed list of key startups/SMEs 227 11.8.5.2 Competitive benchmarking of key startups/SMEs 228 11.9 COMPETITIVE SCENARIO 229 11.9.1 PRODUCT LAUNCHES 229 11.9.2 DEALS 232 11.9.3 EXPANSIONS 236 12 COMPANY PROFILES 241 12.1 KEY PLAYERS 241 12.1.1 AMCOR PLC (INCLUDING BERRY GLOBAL) 241 12.1.1.1 Business overview 241 12.1.1.2 Products/Solutions/Services offered 242 12.1.1.3 Recent developments 244 12.1.1.3.1 Product launches 244 12.1.1.3.2 Deals 245 12.1.1.3.3 Expansions 245 12.1.1.4 MnM view 246 12.1.1.4.1 Right to win 246 12.1.1.4.2 Strategic choices 246 12.1.1.4.3 Weaknesses and competitive threats 247 12.1.2 GERRESHEIMER AG 248 12.1.2.1 Business overview 248 12.1.2.2 Products/Solutions/Services offered 249 12.1.2.3 Recent developments 251 12.1.2.3.1 Product launches 251 12.1.2.3.2 Deals 252 12.1.2.3.3 Expansions 253 12.1.2.4 MnM view 254 12.1.2.4.1 Right to win 254 12.1.2.4.2 Strategic choices 254 12.1.2.4.3 Weaknesses and competitive threats 254 12.1.3 SCHOTT AG 255 12.1.3.1 Business overview 255 12.1.3.2 Products/Solutions/Services offered 256 12.1.3.3 Recent developments 257 12.1.3.3.1 Product launches 257 12.1.3.3.2 Deals 258 12.1.3.3.3 Expansions 258 12.1.3.4 MnM view 259 12.1.3.4.1 Right to win 259 12.1.3.4.2 Strategic choices 259 12.1.3.4.3 Weaknesses and competitive threats 260 12.1.4 APTARGROUP, INC. 261 12.1.4.1 Business overview 261 12.1.4.2 Products/Solutions/Services offered 262 12.1.4.3 Recent developments 263 12.1.4.3.1 Product launches 263 12.1.4.3.2 Deals 264 12.1.4.4 MnM view 265 12.1.4.4.1 Right to win 265 12.1.4.4.2 Strategic choices 265 12.1.4.4.3 Weaknesses and competitive threats 265 12.1.5 BD 266 12.1.5.1 Business overview 266 12.1.5.2 Products/Solutions/Services offered 268 12.1.5.3 Recent developments 268 12.1.5.3.1 Product launches 268 12.1.5.3.2 Deals 269 12.1.5.3.3 Expansions 270 12.1.5.4 MnM view 270 12.1.5.4.1 Right to win 270 12.1.5.4.2 Strategic choices 270 12.1.5.4.3 Weaknesses & competitive threats 271 12.1.6 WESTROCK COMPANY 272 12.1.6.1 Business overview 272 12.1.6.2 Products/Solutions/Services offered 273 12.1.6.3 Recent developments 273 12.1.6.3.1 Deals 273 12.1.6.4 MnM view 273 12.1.7 NIPRO 274 12.1.7.1 Business overview 274 12.1.7.2 Products/Solutions/Services offered 275 12.1.7.3 Recent developments 276 12.1.7.3.1 Product launches 276 12.1.7.4 MnM view 276 12.1.8 CATALENT, INC 277 12.1.8.1 Business overview 277 12.1.8.2 Products/Solutions/Services offered 278 12.1.8.3 Recent developments 279 12.1.8.3.1 Deals 279 12.1.8.3.2 Expansions 280 12.1.8.4 MnM view 281 12.1.9 SEALED AIR 282 12.1.9.1 Business overview 282 12.1.9.2 Products/Solutions/Services offered 283 12.1.9.3 Recent developments 284 12.1.9.3.1 Product launches 284 12.1.9.3.2 Deals 284 12.1.9.4 MnM view 285 12.1.10 WEST PHARMACEUTICAL SERVICES, INC. 286 12.1.10.1 Business overview 286 12.1.10.2 Products/Solutions/Services offered 287 12.1.10.3 Recent developments 288 12.1.10.3.1 Product launches 288 12.1.10.3.2 Deals 289 12.1.10.3.3 Expansions 289 12.1.10.4 MnM view 290 12.2 OTHER PLAYERS 291 12.2.1 ALPLA 291 12.2.2 ARDAGH GROUP S.A. 292 12.2.3 CCL INDUSTRIES INC. 293 12.2.4 FRANK NOE 294 12.2.5 GAPLAST GMBH 295 12.2.6 LONZA 296 12.2.7 MONDI 297 12.2.8 NOLATO AB 298 12.2.9 ORIGIN PHARMA PACKAGING 299 12.2.10 COMAR 300 12.2.11 BILCARE LIMITED 301 12.2.12 SGD PHARMA 302 12.2.13 SILGAN PLASTICS 303 12.2.14 VETTER PHARMA INTERNATIONAL GMBH 304 12.2.15 SVAM TOYAL PACKAGING INDUSTRIES PVT. LTD. 305 13 APPENDIX 306 13.1 DISCUSSION GUIDE 306 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 310 13.3 CUSTOMIZATION OPTIONS 312 13.4 RELATED REPORTS 312 13.5 AUTHOR DETAILS 313

圖表清單 List of Tables & Figures

TABLE 1 INCLUSIONS AND EXCLUSIONS 30 TABLE 2 SUMMARY OF CHANGES 32 TABLE 1 LIST OF KEY SECONDARY SOURCES 34 TABLE 2 RISK ASSESSMENT 41 TABLE 3 ROLES OF COMPANIES IN PHARMACEUTICAL PACKAGING ECOSYSTEM 57 TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 60 TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 60 TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 61 TABLE 7 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 61 TABLE 8 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 62 TABLE 9 IMPORT SCENARIO FOR HS CODE 392310-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 64 TABLE 10 EXPORT SCENARIO FOR HS CODE 392310-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 65 TABLE 11 INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL PACKAGING OFFERED BY KEY PLAYERS, BY RAW MATERIAL, 2023-2030 (USD/KG) 66 TABLE 12 INDICATIVE AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING, BY REGION, 2023–2030 (USD/KG) 67 TABLE 13 PHARMACEUTICAL PACKAGING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 73 TABLE 14 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET 76 TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE TYPES 78 TABLE 16 KEY BUYING CRITERIA FOR KEY TYPES 79 TABLE 17 GLOBAL GDP GROWTH PROJECTION, BY REGION, 2021–2028 (USD TRILLION) 80 TABLE 18 PHARMACEUTICAL PACKAGING MARKET, PACKAGING TYPE, 2022–2024 (USD MILLION) 84 TABLE 19 PHARMACEUTICAL PACKAGING MARKET, PACKAGING TYPE, 2025–2030 (USD MILLION) 84 TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION) 87 TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION) 88 TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KILOTON) 88 TABLE 23 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2025–2030 (KILOTON) 88 TABLE 24 PHARMACEUTICAL PLASTIC PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION) 89 TABLE 25 PHARMACEUTICAL PLASTIC PACKAGING MARKET, BY REGION, 2025–2030 (USD MILLION) 89 TABLE 26 PHARMACEUTICAL PAPER & PAPERBOARD PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION) 92 TABLE 27 PHARMACEUTICAL PAPER & PAPERBOARD PACKAGING MARKET, BY REGION, 2025–2030 (USD MILLION) 92 TABLE 28 PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION) 93 TABLE 29 PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION, 2025–2030 (USD MILLION) 93 TABLE 30 TYPES OF GLASS USED FOR DIFFERENT PACKAGING 94 TABLE 31 PHARMACEUTICAL METAL PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION) 95 TABLE 32 PHARMACEUTICAL METAL PACKAGING MARKET, BY REGION, 2025–2030 (USD MILLION) 96 TABLE 33 OTHER PHARMACEUTICAL PACKAGING RAW MATERIALS MARKET, BY REGION, 2022–2024 (USD MILLION) 96 TABLE 34 OTHER PHARMACEUTICAL PACKAGING RAW MATERIALS MARKET, BY REGION, 2025–2030 (USD MILLION) 97 TABLE 35 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION) 100 TABLE 36 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025–2030 (USD MILLION) 100 TABLE 37 PHARMACEUTICAL PACKAGING MARKET FOR ORAL DRUGS, BY REGION, 2022–2024 (USD MILLION) 101 TABLE 38 PHARMACEUTICAL PACKAGING MARKET FOR ORAL DRUGS, BY REGION, 2025–2030 (USD MILLION) 101 TABLE 39 PHARMACEUTICAL PACKAGING MARKET FOR INJECTABLE DRUGS, BY REGION, 2022–2024 (USD MILLION) 102 TABLE 40 PHARMACEUTICAL PACKAGING MARKET FOR INJECTABLE DRUGS, BY REGION, 2025–2030 (USD MILLION) 102 TABLE 41 PHARMACEUTICAL PACKAGING MARKET FOR TOPICAL DRUGS, BY REGION, 2022–2024 (USD MILLION) 103 TABLE 42 PHARMACEUTICAL PACKAGING MARKET FOR TOPICAL DRUGS, BY REGION, 2025–2030 (USD MILLION) 103 TABLE 43 PHARMACEUTICAL PACKAGING MARKET FOR OCULAR/OPHTHALMIC DRUGS, BY REGION, 2022–2024 (USD MILLION) 104 TABLE 44 PHARMACEUTICAL PACKAGING MARKET FOR OCULAR/OPHTHALMIC DRUGS, BY REGION, 2025–2030 (USD MILLION) 105 TABLE 45 PHARMACEUTICAL PACKAGING MARKET FOR NASAL DRUGS, BY REGION, 2022–2024 (USD MILLION) 105 TABLE 46 PHARMACEUTICAL PACKAGING MARKET FOR NASAL DRUGS, BY REGION, 2025–2030 (USD MILLION) 106 TABLE 47 PHARMACEUTICAL PACKAGING MARKET FOR PULMONARY DRUGS, BY REGION, 2022–2024 (USD MILLION) 107 TABLE 48 PHARMACEUTICAL PACKAGING MARKET FOR PULMONARY DRUGS, BY REGION, 2025–2030 (USD MILLION) 107 TABLE 49 PHARMACEUTICAL PACKAGING MARKET FOR TRANSDERMAL DRUGS, BY REGION, 2022–2024 (USD MILLION) 108 TABLE 50 PHARMACEUTICAL PACKAGING MARKET FOR TRANSDERMAL DRUGS, BY REGION, 2025–2030 (USD MILLION) 108 TABLE 51 PHARMACEUTICAL PACKAGING MARKET FOR INTRAVENOUS DRUGS, BY REGION, 2022–2024 (USD MILLION) 109 TABLE 52 PHARMACEUTICAL PACKAGING MARKET FOR INTRAVENOUS DRUGS, BY REGION, 2025–2030 (USD MILLION) 109 TABLE 53 PHARMACEUTICAL PACKAGING MARKET FOR OTHER DRUG DELIVERY MODES, BY REGION, 2022–2024 (USD MILLION) 110 TABLE 54 PHARMACEUTICAL PACKAGING MARKET FOR OTHER DRUG DELIVERY MODES, BY REGION, 2025–2030 (USD MILLION) 110 TABLE 55 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 113 TABLE 56 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 114 TABLE 57 PHARMACEUTICAL PLASTIC BOTTLES MARKET, BY REGION, 2022–2024 (USD MILLION) 115 TABLE 58 PHARMACEUTICAL PLASTIC BOTTLES MARKET, BY REGION, 2025–2030 (USD MILLION) 115 TABLE 59 PHARMACEUTICAL BLISTER PACKS MARKET, BY REGION, 2022–2024 (USD MILLION) 116 TABLE 60 PHARMACEUTICAL BLISTER PACKS MARKET, BY REGION, 2025–2030 (USD MILLION) 117 TABLE 61 PHARMACEUTICAL LABELS & ACCESSORIES MARKET, BY REGION, 2022–2024 (USD MILLION) 118 TABLE 62 PHARMACEUTICAL LABELS & ACCESSORIES MARKET, BY REGION, 2025–2030 (USD MILLION) 118 TABLE 63 PHARMACEUTICAL CAPS & CLOSURES MARKET, BY REGION, 2022–2024 (USD MILLION) 120 TABLE 64 PHARMACEUTICAL CAPS & CLOSURES MARKET, BY REGION, 2025–2030 (USD MILLION) 120 TABLE 65 MEDICAL SPECIALTY BAGS MARKET, BY REGION, 2022–2024 (USD MILLION) 121 TABLE 66 MEDICAL SPECIALTY BAGS MARKET, BY REGION, 2025–2030 (USD MILLION) 121 TABLE 67 PHARMACEUTICAL PREFILLED SYRINGES MARKET, BY REGION, 2022–2024 (USD MILLION) 122 TABLE 68 PHARMACEUTICAL PREFILLED SYRINGES MARKET, BY REGION, 2025–2030 (USD MILLION) 122 TABLE 69 PHARMACEUTICAL TEMPERATURE-CONTROLLED PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION) 123 TABLE 70 PHARMACEUTICAL TEMPERATURE-CONTROLLED PACKAGING MARKET, BY REGION, 2025–2030 (USD MILLION) 123 TABLE 71 PHARMACEUTICAL POUCHES & STRIP PACKS MARKET, BY REGION, 2022–2024 (USD MILLION) 124 TABLE 72 PHARMACEUTICAL POUCHES & STRIP PACKS MARKET, BY REGION, 2025–2030 (USD MILLION) 124 TABLE 73 PHARMACEUTICAL AMPOULES MARKET, BY REGION, 2022–2024 (USD MILLION) 125 TABLE 74 PHARMACEUTICAL AMPOULES MARKET, BY REGION, 2025–2030 (USD MILLION) 125 TABLE 75 PHARMACEUTICAL VIALS MARKET, BY REGION, 2022–2024 (USD MILLION) 126 TABLE 76 PHARMACEUTICAL VIALS MARKET, BY REGION, 2025–2030 (USD MILLION) 126 TABLE 77 PHARMACEUTICAL PREFILLED INHALERS MARKET, BY REGION, 2022–2024 (USD MILLION) 127 TABLE 78 PHARMACEUTICAL PREFILLED INHALERS MARKET, BY REGION, 2025–2030 (USD MILLION) 127 TABLE 79 PHARMACEUTICAL MEDICATION TUBES MARKET, BY REGION, 2022–2024 (USD MILLION) 128 TABLE 80 PHARMACEUTICAL MEDICATION TUBES MARKET, BY REGION, 2025–2030 (USD MILLION) 128 TABLE 81 PHARMACEUTICAL JARS & CANISTERS MARKET, BY REGION, 2022–2024 (USD MILLION) 129 TABLE 82 PHARMACEUTICAL JARS & CANISTERS MARKET, BY REGION, 2025–2030 (USD MILLION) 130 TABLE 83 PHARMACEUTICAL CARTRIDGES MARKET, BY REGION, 2022–2024 (USD MILLION) 130 TABLE 84 PHARMACEUTICAL CARTRIDGES MARKET, BY REGION, 2025–2030 (USD MILLION) 131 TABLE 85 OTHER PHARMACEUTICAL PACKAGING TYPES MARKET, BY REGION, 2022–2024 (USD MILLION) 131 TABLE 86 OTHER PHARMACEUTICAL PACKAGING TYPES MARKET, BY REGION, 2025–2030 (USD MILLION) 132 TABLE 87 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION) 134 TABLE 88 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2025–2030 (USD MILLION) 134 TABLE 89 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 136 TABLE 90 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 136 TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 136 TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 137 TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION) 137 TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION) 137 TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION) 138 TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025–2030 (USD MILLION) 138 TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION) 139 TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION) 139 TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT) 139 TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT) 140 TABLE 101 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 141 TABLE 102 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 142 TABLE 103 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 143 TABLE 104 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 144 TABLE 105 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 145 TABLE 106 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 146 TABLE 107 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 147 TABLE 108 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 147 TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 148 TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 149 TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION) 149 TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION) 149 TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION) 150 TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE, 2025–2030 (USD MILLION) 150 TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION) 151 TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION) 151 TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT) 151 TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT) 152 TABLE 119 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 153 TABLE 120 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 154 TABLE 121 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 155 TABLE 122 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 156 TABLE 123 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 157 TABLE 124 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 158 TABLE 125 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 159 TABLE 126 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 160 TABLE 127 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 161 TABLE 128 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 162 TABLE 129 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 163 TABLE 130 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 164 TABLE 131 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 165 TABLE 132 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 166 TABLE 133 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 167 TABLE 134 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 168 TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 168 TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 169 TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION) 169 TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION) 169 TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION) 170 TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2025–2030 (USD MILLION) 170 TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION) 171 TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION) 171 TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT) 171 TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT) 172 TABLE 145 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 173 TABLE 146 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 174 TABLE 147 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 175 TABLE 148 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 176 TABLE 149 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 177 TABLE 150 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 178 TABLE 151 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 179 TABLE 152 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 180 TABLE 153 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 181 TABLE 154 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 182 TABLE 155 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 183 TABLE 156 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 184 TABLE 157 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 185 TABLE 158 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 185 TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 185 TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 186 TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION) 186 TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION) 186 TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION) 187 TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025–2030 (USD MILLION) 187 TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION) 188 TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION) 188 TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT) 188 TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT) 189 TABLE 169 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 190 TABLE 170 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 191 TABLE 171 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 192 TABLE 172 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 193 TABLE 173 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 194 TABLE 174 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 195 TABLE 175 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 196 TABLE 176 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 196 TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 197 TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 198 TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION) 198 TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION) 198 TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION) 199 TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025–2030 (USD MILLION) 199 TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION) 200 TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION) 200 TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT) 200 TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT) 201 TABLE 187 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 202 TABLE 188 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 203 TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 204 TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 204 TABLE 191 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 205 TABLE 192 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 206 TABLE 193 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION) 207 TABLE 194 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION) 208 TABLE 195 PHARMACEUTICAL PACKAGING MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2020–AUGUST 2025 210 TABLE 196 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION, 2024 212 TABLE 197 PHARMACEUTICAL PACKAGING MARKET: REGIONAL FOOTPRINT, 2024 221 TABLE 198 PHARMACEUTICAL PACKAGING MARKET: RAW MATERIAL FOOTPRINT, 2024 222 TABLE 199 PHARMACEUTICAL PACKAGING MARKET: TYPE FOOTPRINT, 2024 223 TABLE 200 PHARMACEUTICAL PACKAGING MARKET: DRUG DELIVERY FOOTPRINT, 2024 224 TABLE 201 PHARMACEUTICAL PACKAGING MARKET: PACKAGING TYPE FOOTPRINT, 2024 225 TABLE 202 PHARMACEUTICAL PACKAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 227 TABLE 203 PHARMACEUTICAL PACKAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 228 TABLE 204 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020-AUGUST 2025 229 TABLE 205 PHARMACEUTICAL PACKAGING MARKET: DEALS, JANUARY 2020–AUGUST 2025 232 TABLE 206 PHARMACEUTICAL PACKAGING MARKET: EXPANSIONS, JANUARY 2020–AUGUST 2025 237 TABLE 207 AMCOR PLC: COMPANY OVERVIEW 241 TABLE 208 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 242 TABLE 209 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES 244 TABLE 210 PHARMACEUTICAL PACKAGING MARKET: DEALS 245 TABLE 211 PHARMACEUTICAL PACKAGING MARKET: EXPANSIONS 245 TABLE 212 GERRESHEIMER AG: COMPANY OVERVIEW 248 TABLE 213 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 249 TABLE 214 GERRESHEIMER AG: PRODUCT LAUNCHES 251 TABLE 215 GERRESHEIMER AG: DEALS 252 TABLE 216 GERRESHEIMER AG: EXPANSIONS 253 TABLE 217 SCHOTT AG: COMPANY OVERVIEW 255 TABLE 218 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 256 TABLE 219 SCHOTT AG: PRODUCT LAUNCHES 257 TABLE 220 SCHOTT AG: DEALS 258 TABLE 221 SCHOTT AG: EXPANSIONS 258 TABLE 222 APTAR GROUP, INC.: COMPANY OVERVIEW 261 TABLE 223 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 262 TABLE 224 APTAR GROUP, INC.: PRODUCT LAUNCHES 263 TABLE 225 APTAR GROUP, INC.: DEALS 264 TABLE 226 BD: COMPANY OVERVIEW 266 TABLE 227 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 268 TABLE 228 BD: PRODUCT LAUNCHES 268 TABLE 229 BD: DEALS 269 TABLE 230 BD: EXPANSIONS 270 TABLE 231 WESTROCK COMPANY: COMPANY OVERVIEW 272 TABLE 232 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 273 TABLE 233 WESTROCK COMPANY: DEALS 273 TABLE 234 NIPRO: COMPANY OVERVIEW 274 TABLE 235 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275 TABLE 236 NIPRO: PRODUCT LAUNCHES 276 TABLE 237 CATALENT, INC.: COMPANY OVERVIEW 277 TABLE 238 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 278 TABLE 239 CATALENT, INC.: DEALS 279 TABLE 240 CATALENT, INC.: EXPANSIONS 280 TABLE 241 SEALED AIR: COMPANY OVERVIEW 282 TABLE 242 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED 283 TABLE 243 SEALED AIR: PRODUCT LAUNCHES 284 TABLE 244 SEALED AIR: DEALS 284 TABLE 245 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW 286 TABLE 246 WEST PHARMACEUTICAL SERVICES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 287 TABLE 247 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES 288 TABLE 248 WEST PHARMACEUTICAL SERVICES: DEALS 289 TABLE 249 WEST PHARMACEUTICAL SERVICES: EXPANSIONS 289 TABLE 250 ALPLA: COMPANY OVERVIEW 291 TABLE 251 ARDAGH GROUP S.A.: COMPANY OVERVIEW 292 TABLE 252 CCL INDUSTRIES INC.: COMPANY OVERVIEW 293 TABLE 253 FRANK NOE: COMPANY OVERVIEW 294 TABLE 254 GAPLAST GMBH: COMPANY OVERVIEW 295 TABLE 255 LONZA: COMPANY OVERVIEW 296 TABLE 256 MONDI: COMPANY OVERVIEW 297 TABLE 257 NOLATO AB: COMPANY OVERVIEW 298 TABLE 258 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW 299 TABLE 259 COMAR: COMPANY OVERVIEW 300 TABLE 260 BILCARE LIMITED: COMPANY OVERVIEW 301 TABLE 261 SGD PHARMA: COMPANY OVERVIEW 302 TABLE 262 SILGAN PLASTICS: COMPANY OVERVIEW 303 TABLE 263 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW 304 TABLE 264 SVAM TOYAL PACKAGING INDUSTRIES PVT. LTD.: COMPANY OVERVIEW 305 FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION AND REGIONAL SCOPE 29 FIGURE 2 STUDY YEARS CONSIDERED 31 FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN 33 FIGURE 1 KEY DATA FROM SECONDARY SOURCES 34 FIGURE 2 KEY DATA FROM PRIMARY SOURCES 35 FIGURE 3 KEY INDUSTRY INSIGHTS 36 FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 36 FIGURE 2 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH 37 FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH 38 FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION 39 FIGURE 5 RESEARCH ASSUMPTIONS 40 FIGURE 6 LIMITATIONS 41 FIGURE 7 PLASTIC BOTTLES SEGMENT TO LEAD AMONG PACKAGE TYPES IN 2025 AND 2030 43 FIGURE 8 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD 44 FIGURE 9 PLASTIC SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 44 FIGURE 10 INJECTABLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 45 FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET 46 FIGURE 12 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 47 FIGURE 13 PLASTICS SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD 47 FIGURE 14 PLASTIC BOTTLES SEGMENT TO BE LARGEST MARKET 48 FIGURE 15 PRIMARY PHARMACEUTICAL PACKAGING SEGMENT TO RECORD LARGEST MARKET AND FASTEST GROWTH DURING FORECAST PERIOD 48 FIGURE 16 INJECTABLES SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD 49 FIGURE 17 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD 49 FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET 51 FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN PHARMACEUTICAL PACKAGING MARKET 56 FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM 57 FIGURE 21 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS 58 FIGURE 22 IMPORT DATA FOR HS CODE 392310-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020–2024 (USD MILLION) 64 FIGURE 24 PATENTS APPLIED AND GRANTED, 2014–2024 69 FIGURE 25 LEGAL STATUS OF PATENTS, 2014–2024 70 FIGURE 26 TOP JURISDICTIONS 70 FIGURE 27 PHARMACEUTICAL PACKAGING MARKET: INVESTOR DEALS AND FUNDING TRENDS, 2020–2024 (USD MILLION) 74 FIGURE 28 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET 75 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE TYPES 78 FIGURE 31 PRIMARY PACKAGING SEGMENT TO DOMINATE OVERALL PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 84 FIGURE 32 PHARMACEUTICAL PLASTIC PACKAGING TO DOMINATE PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 87 FIGURE 33 INJECTABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024 99 FIGURE 34 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 112 FIGURE 35 NORTH AMERICA: MARKET SNAPSHOT 135 FIGURE 36 ASIA PACIFIC: MARKET SNAPSHOT 167 FIGURE 37 PHARMACEUTICAL PACKAGING MARKET SHARE ANALYSIS, 2024 212 FIGURE 38 PHARMACEUTICAL PACKAGING MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2020–2024 (USD BILLION) 215 FIGURE 39 PHARMACEUTICAL PACKAGING MARKET: COMPANY VALUATION, 2024 (USD BILLION) 216 FIGURE 40 PHARMACEUTICAL PACKAGING MARKET: FINANCIAL MATRIX: EV/EBITDA RATIO, 2024 216 FIGURE 41 PHARMACEUTICAL PACKAGING MARKET: YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA, 2024 217 FIGURE 42 PHARMACEUTICAL PACKAGING MARKET: PRODUCT/BRAND COMPARISON 218 FIGURE 43 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 220 FIGURE 44 PHARMACEUTICAL PACKAGING MARKET: COMPANY FOOTPRINT, 2024 221 FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 226 FIGURE 46 AMCOR PLC: COMPANY SNAPSHOT 242 FIGURE 47 GERRESHEIMER AG: COMPANY SNAPSHOT 249 FIGURE 48 SCHOTT AG: COMPANY SNAPSHOT 256 FIGURE 49 APTARGROUP, INC.: COMPANY SNAPSHOT 262 FIGURE 50 BD: COMPANY SNAPSHOT 267 FIGURE 51 WESTROCK COMPANY: COMPANY SNAPSHOT 272 FIGURE 52 NIPRO: COMPANY SNAPSHOT 275 FIGURE 53 CATALENT, INC.: COMPANY SNAPSHOT 277 FIGURE 54 SEALED AIR: COMPANY SNAPSHOT 283 FIGURE 55 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT 287

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（化學與材料）